These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15557326)

  • 1. Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
    Ozvegy-Laczka C; Várady G; Köblös G; Ujhelly O; Cervenak J; Schuetz JD; Sorrentino BP; Koomen GJ; Váradi A; Német K; Sarkadi B
    J Biol Chem; 2005 Feb; 280(6):4219-27. PubMed ID: 15557326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
    Ozvegy C; Váradi A; Sarkadi B
    J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter.
    Ozvegy-Laczka C; Laczkó R; Hegedus C; Litman T; Várady G; Goda K; Hegedus T; Dokholyan NV; Sorrentino BP; Váradi A; Sarkadi B
    J Biol Chem; 2008 Sep; 283(38):26059-70. PubMed ID: 18644784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
    Henriksen U; Gether U; Litman T
    J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of breast cancer resistance protein ABCG2 and role of arginine-482.
    Pozza A; Perez-Victoria JM; Sardo A; Ahmed-Belkacem A; Di Pietro A
    Cell Mol Life Sci; 2006 Aug; 63(16):1912-22. PubMed ID: 16847575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state.
    Sauna ZE; Nandigama K; Ambudkar SV
    J Biol Chem; 2004 Nov; 279(47):48855-64. PubMed ID: 15364914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
    Maki N; Moitra K; Ghosh P; Dey S
    J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
    Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
    Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
    Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
    Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding.
    Ejendal KF; Diop NK; Schweiger LC; Hrycyna CA
    Protein Sci; 2006 Jul; 15(7):1597-607. PubMed ID: 16815914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
    Robey RW; Obrzut T; Shukla S; Polgar O; Macalou S; Bahr JC; Di Pietro A; Ambudkar SV; Bates SE
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):575-83. PubMed ID: 19132374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain.
    Hou YX; Cui L; Riordan JR; Chang XB
    J Biol Chem; 2002 Feb; 277(7):5110-9. PubMed ID: 11741902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporter.
    Rao DK; Liu H; Ambudkar SV; Mayer M
    J Biol Chem; 2014 Nov; 289(45):31397-410. PubMed ID: 25253691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2).
    Zattoni IF; Kronenberger T; Kita DH; Guanaes LD; Guimarães MM; de Oliveira Prado L; Ziasch M; Vesga LC; Gomes de Moraes Rego F; Picheth G; Gonçalves MB; Noseda MD; Ducatti DRB; Poso A; Robey RW; Ambudkar SV; Moure VR; Gonçalves AG; Valdameri G
    Chem Biol Interact; 2022 Jan; 351():109718. PubMed ID: 34717915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions.
    Glavinas H; Kis E; Pál A; Kovács R; Jani M; Vági E; Molnár E; Bánsághi S; Kele Z; Janáky T; Báthori G; von Richter O; Koomen GJ; Krajcsi P
    Drug Metab Dispos; 2007 Sep; 35(9):1533-42. PubMed ID: 17537873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A time-resolved Förster resonance energy transfer assay to investigate drug and inhibitor binding to ABCG2.
    Mitchell-White JI; Briggs DA; Mistry SJ; Mbiwan HA; Kellam B; Holliday ND; Briddon SJ; Kerr ID
    Arch Biochem Biophys; 2024 Mar; 753():109915. PubMed ID: 38307314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2.
    Shukla S; Wu CP; Nandigama K; Ambudkar SV
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3279-86. PubMed ID: 18065489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter.
    Telbisz A; Müller M; Ozvegy-Laczka C; Homolya L; Szente L; Váradi A; Sarkadi B
    Biochim Biophys Acta; 2007 Nov; 1768(11):2698-713. PubMed ID: 17662239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.